NASDAQ: BMRA
Biomerica Inc Stock Ownership - Who owns Biomerica?

Insider buying vs selling

Have Biomerica Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Allen BarbieriExecutive Vice Chairman2024-12-13110,000$0.31
$34.10kBuy
Catherine CosteDirector2024-12-1385,000$0.31
$26.35kBuy
Jane EmersonDirector2024-12-1385,000$0.31
$26.35kBuy
Zackary S. IraniChief Executive Officer2024-12-13250,000$0.31
$77.50kBuy
Gary LuChief Financial Officer2024-12-13155,000$0.31
$48.05kBuy
David MoatazediDirector2024-12-1385,000$0.31
$26.35kBuy

1 of 1

BMRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRA insiders and whales buy or sell their stock.

BMRA Shareholders

What type of owners hold Biomerica Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janet Moore92.53%2,605,228$7.76MInsider
Zackary S. Irani45.13%1,270,560$3.79MInsider
Janet Trust Dtd 8. Moore22.59%635,977$1.90MInsider
The Broadoak Fund17.76%500,000$1.49MInsider
William Snider17.76%500,000$1.49MInsider
Allen Barbieri6.69%188,337$561.24kInsider
Jane Emerson5.54%156,000$464.88kInsider
Gary Lu5.51%155,000$461.90kInsider
Francis Cano5.42%152,636$454.86kInsider
Catherine Coste4.90%137,890$410.91kInsider

1 of 3

BMRA vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRA1.06%98.94%Net Buying
HSDT0.93%99.07%
HSCS2.28%1.21%Net SellingNet Selling
LFWD1.40%98.60%Net SellingNet Selling
PAVM5.59%87.52%

Biomerica Stock Ownership FAQ

Who owns Biomerica?

Biomerica (NASDAQ: BMRA) is owned by 2.47% institutional shareholders, 230.60% Biomerica insiders, and 0.00% retail investors. Janet Moore is the largest individual Biomerica shareholder, owning 2.61M shares representing 92.53% of the company. Janet Moore's Biomerica shares are currently valued at $7.76M.

If you're new to stock investing, here's how to buy Biomerica stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.